Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China.
Curr Diab Rep. 2021 Sep 8;21(10):38. doi: 10.1007/s11892-021-01404-5.
The strength of the relationship between diabetes, diabetic retinopathy (DR), and glaucoma remains controversial. We review evidence supporting and refuting this association and explore mechanistic pathological and treatment relationships linking these diseases.
While studies have shown diabetes/DR may increase the risk for glaucoma, this remains inconsistently demonstrated. Diabetes/DR may contribute toward glaucomatous optic neuropathy indirectly (either by increasing intraocular pressure or vasculopathy) or through direct damage to the optic nerve. However, certain elements of diabetes may slow glaucoma progression, and diabetic treatment may concurrently be beneficial in glaucoma management. Diabetes plays a significant role in poor outcomes after glaucoma surgery. While the relationship between diabetes/DR and glaucoma remains controversial, multiple mechanistic links connecting pathophysiology and management of diabetes, DR, and glaucoma have been made. However, a deeper understanding of the causes of disease association is needed.
糖尿病、糖尿病性视网膜病变(DR)和青光眼之间的关系强度仍存在争议。我们综述了支持和反驳这种关联的证据,并探讨了将这些疾病联系起来的病理机制和治疗关系。
虽然研究表明糖尿病/DR 可能会增加青光眼的风险,但这一点并不一致。糖尿病/DR 可能通过间接(通过增加眼内压或血管病变)或通过对视神经的直接损伤导致青光眼性视神经病变。然而,糖尿病的某些因素可能会减缓青光眼的进展,而且糖尿病的治疗对青光眼的管理也可能有益。糖尿病在青光眼手术后的不良结局中起着重要作用。虽然糖尿病/DR 和青光眼之间的关系仍存在争议,但已经建立了将糖尿病、DR 和青光眼的病理生理学和管理联系起来的多种机制联系。然而,需要更深入地了解疾病关联的原因。